StockData
Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc. (AGIO) stock

AGIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/308% above fair value
$29.89−0.26 (-0.86%)

Close on Nov 17, 2026Market cap $1.78BP/E –Yield –

Agios Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Agios Pharmaceuticals's price to book ratio was 1.9× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.9× to 4.0×, with a median of 1.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×+0.7
2025Dec 31, 20251.2×+0.1
2024Dec 31, 20241.2×−0.3
2023Dec 29, 20231.4×−0.1
2022Dec 30, 20221.5×+0.2
2021Dec 31, 20211.3×−5.0
2020Dec 31, 20206.2×−0.0
2019Dec 31, 20196.3×+2.7
2018Dec 31, 20183.5×−2.7
2017Dec 29, 20176.2×+1.8
2016Dec 30, 20164.4×−2.1
2015Dec 31, 20156.5×−12.2
2014Dec 31, 201418.7×+13.5
2013Dec 31, 20135.2×–

More Agios Pharmaceuticals figures

See a number that looks wrong?